Connection

WILLIAM LAGOR to Atherosclerosis

This is a "connection" page, showing publications WILLIAM LAGOR has written about Atherosclerosis.
Connection Strength

1.335
  1. In Vivo Gene Editing in Lipid and Atherosclerosis Research. Methods Mol Biol. 2022; 2419:673-713.
    View in: PubMed
    Score: 0.444
  2. Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research. Arterioscler Thromb Vasc Biol. 2018 09; 38(9):1997-2006.
    View in: PubMed
    Score: 0.353
  3. Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis. Atherosclerosis. 2014 Mar; 233(1):234-41.
    View in: PubMed
    Score: 0.256
  4. High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner. Atherosclerosis. 2023 11; 384:117150.
    View in: PubMed
    Score: 0.122
  5. Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Ldlr-/- Mice. Arterioscler Thromb Vasc Biol. 2020 01; 40(1):72-85.
    View in: PubMed
    Score: 0.095
  6. Phospholipidation of HDL--how much is too much? Clin Chem. 2011 Jan; 57(1):4-6.
    View in: PubMed
    Score: 0.051
  7. Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter. Atherosclerosis. 2011 Sep; 218(1):77-82.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.